Cases 51 - 60 of 2,302
ALLENDE REVA v. Boehringer Ingelheim Corp. et al
as 9:2023cv80050
Plaintiff:
BALTASAR ALLENDE REVA
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAKER v. GLAXOSMITHKLINE INC. et al
as 9:2023cv80053
Plaintiff:
ROBIN BAKER
Defendant:
GLAXOSMITHKLINE INC., GlaxoSmithKline LLC, Amneal Pharmaceuticals of New York, LLC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BROWN v. Boehringer Ingelheim Corp. et al
as 9:2023cv80060
Plaintiff:
MICHAEL BROWN
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Vickie Anderson, et al v. Glenmark Pharmaceuticals, Inc. USA, et al
as 23-12743
Plaintiff / Appellant:
VICKIE ANDERSON, ROY ARMSTRONG, JANET ASBURY and others
Defendant / Appellee:
GLENMARK PHARMACEUTICALS, INC. USA, MARLENE GOLDENBERG, APOTEX CORP. and others
Arthur Cartee v. Glenmark Pharmaceuticals, Inc. USA, et al
as 23-12688
Plaintiff / Appellant:
ARTHUR CARTEE
Defendant / Appellee:
GLENMARK PHARMACEUTICALS, INC. USA, MARLENE GOLDENBERG, APOTEX CORP. and others
Elaine Harrell v. Glenmark Pharmaceuticals, Inc. USA, et al
as 23-12664
Plaintiff / Appellant:
ELAINE HARRELL
Defendant / Appellee:
GLENMARK PHARMACEUTICALS, INC. USA, MARLENE GOLDENBERG, APOTEX CORP. and others
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2023cv00774
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Apotex Inc., Apotex Corp., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Justin Johnson v. Glenmark Pharmaceuticals, Inc. USA, et al
as 23-12628
Plaintiff / Appellant:
JUSTIN JOHNSON
Defendant / Appellee:
GLENMARK PHARMACEUTICALS, INC. USA, MARLENE GOLDENBERG, APOTEX CORP. and others
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
